Tilray Brands Inc
TLRY: XTSE (CAN)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
CAD 5.50 | Plcs | Qjnbnvrw |
Tilray's Path to Breakeven Free Cash Flow Is Nearing, but Dilution Remains a Risk to Equityholders
Business Strategy and Outlook
Tilray cultivates and sells cannabis in Canada and exports into the global medical market. It also sells CBD and alcohol. The company is the result of legacy Aphria acquiring legacy Tilray in a reverse merger and taking the target name in 2021.